Levalbuterol toxicity: no reason to be jittery

Abstract

Levalbuterol, the R-isomer of racemic albuterol, is a more effective bronchodilator with fewer side-effects than racemic albuterol [1][2][3]. We present a paediatric patient in status asthmaticus who received twelve times the prescribed dose of levalbuterol and manifested only mild systemic side-effects.This 4-yr-old African-American male was admitted to the Pediatric Intensive Care Unit (Portsmouth, VA, USA) where continuous nebulised levalbuterol was ordered at 0.63 mg?h -1 . The nebuliser chamber was erroneously filled with twelve 0.63 mg unit-dose ampoules, delivering 7.56 mg?h -1 of levalbuterol. This dosing regimen was continued for twelve hours before it was discovered.On the morning rounds, the child was noted to be tachypneic and tachycardic, with a respiratory rate in the mid 40s and cardiac frequency in the range of 150-170 beats?min -1 . Oxygen saturation was 97-100% on an inspiratory oxygen fraction of 0.3. The patient was sleeping without any respiratory difficulty. The levalbuterol dose was reduced to 1.25 mg?h -1 and serum electrolytes were obtained. These were completely within normal limits, including potassium of 4.0 mmol?L -1 . The patient was weaned off continuous nebuliser treatments over the following 8 h and was transferred to the paediatric ward the next day. The remainder of his hospital course was without incident and he was discharged in good condition.Racemic albuterol contains both R-albuterol (levalbuterol), which has bronchodilatory activity, and S-levalbuterol, initially thought to be inert. Studies have demonstrated that the S-levalbuterol not only increases intracellular-free calcium, which is an agonist in airway smooth muscle contraction, but also has significant proinflammatory effects, including increasing the production of histamine and interleukin-4 in mast cells [3][4][5]. These results support the concept that the S-levalbuterol may have significant detrimental effects on pulmonary function in an acute asthma exacerbation. Reported side-effects of levalbuterol in the studies of both NELSON et al.[1] and GAWCHIK et al.[2] included increased heart frequency, tremor and hypokalaemia that were dose related but similar between the two study groups.In the intensive care unit (ICU) setting, dosing of racemic albuterol as high as 20 mg?h -1 in children with status asthmaticus is not uncommon. However, therapeutic dosing of levalbuterol in asthmatics at w1.25 mg has not been previously reported. Tremor, heart rate and hypokalaemia were dose related following inhalation of increasing doses of levalbuterol (0.2-3.2 mg) in normal volunteers. However, our patient received a dose twice that given to these volunteers and experienced only minimal side-effects.We also believe that this may be the first report on the use of continuous levalbuterol nebulisation in an inpatient setting for children. The National Asthma Education Program, Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma-No. 91-3042, recommended using racemic albuterol up to every 1-2 h for moderate...

Acute Levalbuterol Toxicity With Use of Metered Dose Inhaler

“…There are scant reports of toxicity with levalbuterol, and none in small children with use of MDI. Biswas and Fruedenthal 9 reported a case of 4-year male child case of status asthmaticus who received 12 times the prescribed dose of levalbuterol nebulization and manifested only with tachycardia and tachypnea. Another case of a marine recruit developing transient loss of consciousness, prolonged QTc and hypokalemia with excessive use of MDI levalbuterol has been described.…”

Acute levalbuterol toxicity with use of metered dose inhaler

“…There are scant reports of toxicity with levalbuterol, and none in small children with use of MDI. Biswas et al reported a case of 4 year male child case of status asthmaticus who received twelve times the prescribed dose of levalbuterol nebulization and manifested only with tachycardia and tachypnea (9). Another case of a marine recruit developing transient loss of consciousness, prolonged QTc and hypokalemia with excessive use of MDI levalbuterol has been described (10).…”

A Levalbuterol Therapeutic Misadventure

“…Levalbuterol, the R-isomer of albuterol, was marketed to possess fewer cardiac effects than racemic albuterol. There have been rare reports concerning the use or abuse of levalbuterol (2). Two reports note that QT prolongation and hypokalemic effects of levalbuterol are similar to racemic albuterol (3,4).…”